Insights from “The Participation Equation” and why putting the human experience first matters
The clinical research landscape is more complex than ever. Hybrid and decentralized models have expanded access, increased diversity, and reduced site burden. At the same time, the rise of digital tools has introduced new challenges in maintaining the human connection that keeps patients engaged.
The recent report The Participation Equation by Cuttsy+Cuttsy, created with the International Society for Patient Engagement Professionals (ISPEP), offers meaningful insights into what encourages participants to join, stay in, and complete clinical trials.
At mdgroup, our mission is to deliver the personalized experience patients and their caregivers deserve when taking part in clinical trials. That means designing and delivering trials powered by a real understanding of the patient experience. This blog explores the most important findings from the research, aligns them with mdgroup’s services, and provides practical steps for sponsors, CROs, and sites.
Key findings from the report
1. How people find trials is changing
-
45% of respondents said they learned about trial opportunities on social media instead of from their healthcare provider.
-
This shift shows how proactive participants have become, but also how critical it is to support them once they express interest.
2. Experience directly impacts completion
-
Participants who reported that they “definitely” felt supported had a 92% completion rate.
-
This reinforces that support, connection, and positive experiences are not extras. They are central to a study’s success.
3. Human connection and meaningful resources matter
-
The research highlights the importance of empathetic human contact, along with clear communication and logistical support.
-
Technology alone cannot deliver the reassurance and understanding that people need during a trial.
4. Participants weigh burden and benefit in very personal ways
-
People evaluate trials not only on scientific merit, but also on time, travel, flexibility, and emotional toll.
-
Designs that overlook these factors risk poor retention and incomplete data.
5. Trial design must reflect real lives
-
The report notes that protocols often assume an ideal participant and an ideal schedule, instead of the diversity of real people.
-
Truly patient centric trials must plan for real-world needs and obstacles.
Why this matters to mdgroup and our clients
The findings reinforce the importance of designing clinical trials around real participant needs, something central to mdgroup’s service offering.
Our work supports the full clinical journey, from recruitment through long-term retention. The insights from The Participation Equation highlight several areas where mdgroup’s services directly address the challenges participants face.
Positive patient experience drives trial completion
mdgroup’s decentralized clinical trial procedures, flexible scheduling, and concierge-style support reduce burden and create a smoother experience that helps keep participants engaged and active in the study.
Support needs to be consistent and personal
Our global patient support teams and network of highly trained nurses provide compassionate, reliable human contact. Participants feel supported throughout the trial, which increases trust and improves overall retention.
Logistical barriers must be minimized
Through patient travel, accommodation, and relocation services, mdgroup removes common obstacles that prevent participants from joining or staying enrolled. This includes flights, ground transport, visas, hotel stays, and caregiver support.
Trials must adapt to the realities of participants’ lives
Our digital-first coordination platform enables seamless management of home visits, reminders, communication, and data capture. This keeps participants informed and reduces daily burden.
Clear communication improves understanding and confidence
Our teams ensure patients receive tailored, accessible, multilingual communication that makes the clinical journey easier to navigate.
Together, these services create the kind of experience that the research identifies as essential for improving recruitment, retention, and trial success. The findings validate the need for patient-first operational support, and mdgroup is uniquely positioned to deliver it.
Practical actions for sponsors, CROs, and sites
1. Map the entire participant journey
Look beyond site visits. Consider how people discover trials, evaluate whether to join, experience their visits or home-based procedures, and feel supported throughout the process. Identify friction points early.
2. Build strong support from the start
Check-ins, clear instructions, orientation materials, and real human contact build trust and belonging. These efforts pay off in higher retention.
3. Reduce participation burden
Travel time, visit complexity, and time away from work or family impact trial decisions.
Home-based clinical procedures, patient travel and accommodation support, and flexible scheduling all reduce barriers.
4. Design with inclusivity in mind
Use patient personas, consider literacy levels, provide translated materials, and account for digital access. Make participation possible for people from all backgrounds.
5. Measure participant experience
Track experience as a core operational metric. Feedback loops and real-time data allow study teams to adapt before problems lead to dropouts. mdgroup can help integrate these systems into ongoing trials.
Looking ahead: the future of patient centric research
The Participation Equation highlights several priorities for the industry:
-
Trials that are truly ready for participants, not just informed by them
-
Digital and human support working together
-
Real-time experience data that leads to mid-study improvements
-
Transparent communication throughout the entire trial lifecycle
-
Better access and support for underrepresented groups
At mdgroup, these priorities already guide the way we deliver in-home visits, patient travel and accommodation, care coordination, and patient engagement support. Our goal is to help every participant feel valued, understood, and able to take part on their own terms.
Conclusion
Participation is not a transaction. It is a human experience. For clinical trials to succeed, patients need to feel supported, respected, and confident that the journey is manageable.
The insights from The Participation Equation reinforce what mdgroup stands for: patient driven clinical solutions that improve recruitment, retention, data quality, and overall trial outcomes.
If you would like to explore how mdgroup can help embed these insights into your next study, we’re here to support you.
